0.00Open0.00Pre Close0 Volume0 Open Interest85.00Strike Price0.00Turnover131.11%IV-7.69%PremiumDec 13, 2024Expiry Date6.07Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9238Delta0.0358Gamma12.73Leverage Ratio-0.4993Theta-0.0010Rho-11.76Eff Leverage0.0044Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet